{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:40:47Z","timestamp":1792518047056,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030833","name":"Syneos Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023280","name":"Seqirus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128533","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:45:11Z","timestamp":1775763911000},"page":"128533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness of vaccination of older adults with an MF59\u00ae-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in South Korea and Taiwan"],"prefix":"10.1016","volume":"80","author":[{"given":"Szu-Min","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Joo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Mould-Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jin","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128533_bb0005","unstructured":"World Health Organization (WHO). Influenza (Seasonal) [Internet]. [cited 2024 Dec 20]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"10.1016\/j.vaccine.2026.128533_bb0010","unstructured":"Cost-Effectiveness Analysis of Influenza Disease Burden and Prevention Strategies in Taiwan [Internet]. 2014 Commissioned Science and Technology Research Program; [cited 2025 Feb 18]. Available from: https:\/\/www.cdc.gov.tw\/uploads\/files\/5bd5cfa2-398e-44b0-8d1e-1f517b829468.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128533_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172012","article-title":"Disease burden of 2013-2014 seasonal influenza in adults in Korea","volume":"12","author":"Choi","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128533_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.103998","article-title":"Aging and influenza vaccine-induced immunity","volume":"348","author":"Dugan","year":"2020","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2026.128533_bb0025","unstructured":"The infectious Diseases Society of Taiwan. Supplementary Comments on Influenza Vaccination Guidelines [Internet]. Available from: http:\/\/idsroc.org.tw\/news\/news_info.asp?news_type=4&id=923."},{"issue":"2","key":"10.1016\/j.vaccine.2026.128533_bb0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3947\/ic.2023.0072","article-title":"Recommendations for adult immunization by the korean society of infectious diseases, 2023: minor revisions to the 3rd edition","volume":"56","author":"Choi","year":"2024","journal-title":"Infect Chemother"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128533_bb0035","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.1971017","article-title":"The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom","volume":"17","author":"Kohli","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128533_bb0040","article-title":"The cost-effectiveness of vaccination of older adults with an MF59-Adjuvanted quadrivalent influenza vaccine compared to other available quadrivalent vaccines in Germany","volume":"10","author":"Kohli","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128533_bb0045","article-title":"Cost-effectiveness of vaccination of older adults with an MF59\u00ae-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in Denmark, Norway, and Sweden","volume":"11","author":"Jacob","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.vaccine.2026.128533_bb0050","unstructured":"National flu immunisation programme 2024 to 2025 letter - GOV.UK [Internet]. [cited 2025 Feb 18]. Available from: https:\/\/www.gov.uk\/government\/publications\/national-flu-immunisation-programme-plan-2024-to-2025\/national-flu-immunisation-programme-2024-to-2025-letter."},{"key":"10.1016\/j.vaccine.2026.128533_bb0055","unstructured":"Australian Government - Department of Health and Aged Care. Adults aged \u226565 years are recommended to receive influenza vaccine every year | The Australian Immunisation Handbook [Internet]. [cited 2025 Feb 18]. Available from: https:\/\/immunisationhandbook.health.gov.au\/recommendations\/adults-aged-65-years-are-recommended-to-receive-influenza-vaccine-every-year."},{"issue":"6","key":"10.1016\/j.vaccine.2026.128533_bb0060","article-title":"Vaccines for the elderly and vaccination programs in Europe and the United States","volume":"12","author":"Anastassopoulou","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128533_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40258-022-00721-4","article-title":"Korean guidelines for pharmacoeconomic evaluations: updates in the third version","volume":"20","author":"Bae","year":"2022","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.vaccine.2026.128533_bb0070","unstructured":"Taiwan Center For Drug Evaluation. Guidelines of Methodological Standards for Pharmacoeconomic Evaluations [Internet]. Available from: https:\/\/www.cde.org.tw\/hta\/1444\/1832\/1992\/1994\/18456\/."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128533_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2016.1225636","article-title":"Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: a lifetime multi-cohort model","volume":"13","author":"Yang","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128533_bb0080","unstructured":"Influenza - Taiwan Centers for Disease Control [Internet]. [cited 2024 Dec 23]. Available from: https:\/\/www.cdc.gov.tw\/En\/Category\/ListContent\/bg0g_VU_Ysrgkes_KRUDgQ?uaid=Zvnt3Ff941PorUmUD0-leA."},{"issue":"7","key":"10.1016\/j.vaccine.2026.128533_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies","volume":"167","author":"Carrat","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128533_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3947\/ic.2019.51.2.98","article-title":"The national influenza surveillance system of Korea","volume":"51","author":"Choi","year":"2019","journal-title":"Infect Chemother"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128533_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317643","article-title":"Estimating the clinical and economic burden of medically attended influenza in South Korea, stratified by age and comorbidity: a five-season hospital-based surveillance data, 2014\/15\u20132018\/19","volume":"20","author":"Choi","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128533_bb0100","unstructured":"Health Insurance Review & Assessment Service. Open Data HIRA [Internet]. [cited 2025 Apr 7]. Available from: https:\/\/opendata.hira.or.kr\/op\/opc\/olapMjDiseaseInfoTab1.do."},{"key":"10.1016\/j.vaccine.2026.128533_bb0105","doi-asserted-by":"crossref","unstructured":"Chang YC, Tung HJ, Huang YT, Lu C Te, Ernawaty E, Wu SY. Effect of influenza vaccination on mortality and risk of hospitalization in elderly individuals with and without disabilities: a nationwide, population-based cohort study. Vaccines (Basel). 2020;8(1).","DOI":"10.3390\/vaccines8010112"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128533_bb0110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/vaccines11050933","article-title":"Cost-effectiveness of the use of adjuvanted quadrivalent seasonal influenza vaccine in older adults in Ireland","volume":"11","author":"Nguyen","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128533_bb0115","unstructured":"Centers for Disease Control ROC (Taiwan). Taiwan National Infectious Disease Statistics System [Internet]. [cited 2024 Dec 23]. Available from: https:\/\/nidss.cdc.gov.tw\/en\/Home\/Index?op=2."},{"key":"10.1016\/j.vaccine.2026.128533_bb0120","unstructured":"World Health Organization. Flunet chart [Internet]. [cited 2025 Jun 12]. Available from: https:\/\/worldhealthorg.shinyapps.io\/flunetchart\/."},{"key":"10.1016\/j.vaccine.2026.128533_bb0125","unstructured":"Korea Disease Control and Prevention Agency. Korea National Health and Nutrition Examination Survey (KNHANES) [Internet]. [cited 2025 Apr 7]. Available from: https:\/\/knhanes.kdca.go.kr\/knhanes\/main.do."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128533_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209643","article-title":"Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea","volume":"14","author":"Yun","year":"2019","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128533_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128533_bb0140","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128533_bb0145","unstructured":"Hsiao A, Yee A, Leong T, Zerbo O, Fireman B, Jacobson KB, et al. 164. Effectiveness of adjuvanted inactivated influenza vaccine versus high-dose inactivated influenza vaccine against PCR-confirmed influenza among adults \u226565 years: a pragmatic randomized study. Open Forum Infect Dis 202512(Supplement_1)."},{"key":"10.1016\/j.vaccine.2026.128533_bb0150","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ijid.2022.07.048","article-title":"Comparative effectiveness of adjuvanted versus high-dose seasonal influenza vaccines for older adults: a systematic review and meta-analysis","volume":"122","author":"Domnich","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128533_bb0155","doi-asserted-by":"crossref","unstructured":"Ferdinands JM, Blanton LH, Alyanak E, Chung JR, Trujillo L, Taliano J, et al. Protection against influenza hospitalizations from enhanced influenza vaccines among older adults: a systematic review and network meta-analysis. J Am Geriatr Soc 2024 72(12).","DOI":"10.1111\/jgs.19176"},{"key":"10.1016\/j.vaccine.2026.128533_bb0160","unstructured":"World Economic Outlook (April 2025) - GDP per capita, current prices [Internet]. [cited 2025 May 27]. Available from: https:\/\/www.imf.org\/external\/datamapper\/NGDPDPC@WEO\/OEMDC\/ADVEC\/WEOWORLD\/KOR."},{"key":"10.1016\/j.vaccine.2026.128533_bb0165","unstructured":"National Statistics ROC (Taiwan). Statistical Information [Internet]. [cited 2025 Feb 20]. Available from: https:\/\/www.stat.gov.tw\/cp.aspx?n=2674."},{"issue":"8","key":"10.1016\/j.vaccine.2026.128533_bb0170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40273-020-00915-5","article-title":"Why its time to abandon the ICER","volume":"38","author":"Paulden","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2026.128533_bb0175","doi-asserted-by":"crossref","unstructured":"Postma M, Fisman D, Giglio N, M\u00e1rquez-Pel\u00e1ez S, Nguyen VH, Pugliese A, et al. Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults \u2265 65 Years of Age: Literature Review and Expert Opinion. Vaccines (Basel). 2023 Jun 1;11(6).","DOI":"10.3390\/vaccines11061089"},{"key":"10.1016\/j.vaccine.2026.128533_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001527","article-title":"Assessing optimal target populations for influenza vaccination programmes: An evidence synthesis and modelling study","volume":"10","author":"Baguelin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.128533_bb0185","unstructured":"Statistics Korea. Population Prospects of the World and South Korea (based on the 2021 Population Projections) [Internet]. [cited 2025 Mar 15]. Available from: https:\/\/kostat.go.kr\/board.es?mid=a20108080000&bid=11748&act=view&list_no=420706."},{"key":"10.1016\/j.vaccine.2026.128533_bb0190","unstructured":"Dept. of Household Registration Affairs MOI. Demographic information. Dept of Household Registration Affairs, MOI [Internet]. 2018 [cited 2025 Mar 12]; Available from: https:\/\/www.ris.gov.tw\/app\/portal\/346."},{"issue":"23","key":"10.1016\/j.vaccine.2026.128533_bb0195","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2018.04.063","article-title":"Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis","volume":"36","author":"Somes","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128533_bb0200","unstructured":"Taiwan CDC. Government influenza vaccine purchase decision [Internet]. [cited 2025 Feb 20]. Available from: https:\/\/web.pcc.gov.tw\/tps\/atm\/AtmAwardWithoutSso\/QueryAtmAwardDetail?pkAtmMain=NzA1NTYyMDg=."},{"key":"10.1016\/j.vaccine.2026.128533_bb0205","unstructured":"Taiwan CDC. The procurement operation and selection results of the 113th publicly-funded quadrivalent influenza vaccine [Internet]. [cited 2025 Feb 20]. Available from: https:\/\/www.cdc.gov.tw\/Bulletin\/Detail\/aypxh-KQnRVrimU96R7few?typeid=9."},{"key":"10.1016\/j.vaccine.2026.128533_bb0210","unstructured":"2024\u223c2025 \u201cInfluenza Vaccine\u201d 11.7 million doses procurement contract signed (6.5.Wed) [Internet]. [cited 2025 Apr 7]. Available from: https:\/\/www.kdca.go.kr\/board\/board.es?mid=a20501030000&bid=0015&list_no=725375&cg_code=&act=view&nPage=1&newsField=202406."},{"key":"10.1016\/j.vaccine.2026.128533_bb0215","unstructured":"Ministry of Health and Welfare, Central Health Insurance Administration, Administrative Assistance to the Department of Disease Control \u201c113th Annual Influenza Vaccination Program\u201d Vaccination Disposal Fee Reporting and Payment Operations [Internet]. [cited 2025 May 16]. Available from: https:\/\/www.cdc.gov.tw\/File\/Get\/mz64-c0aWrePkhG4FGFKGg."},{"key":"10.1016\/j.vaccine.2026.128533_bb0220","unstructured":"Korea Disease Control and Prevention Agency, 2024 Vaccination Cost Announcement (April 8, 2024) [Internet]. [cited 2025 Jul 7]. Available from: https:\/\/www.kdca.go.kr\/board\/board.es?mid=a20505000000&bid=0017&tag=&act=view&list_no=725758."},{"key":"10.1016\/j.vaccine.2026.128533_bb0225","unstructured":"Health Insurance Review & Assessment Service. HIRA's non-reimbursable medical expenses data for rapid antigen test fee [Internet]. [cited 2025 Apr 7]. Available from: https:\/\/www.nhis.or.kr\/nbinfo\/wbhfaa06200m28.do?mode=view&articleNo=11000699&title=%EC%9D%B8%ED%94%8C%EB%A3%A8%EC%97%94%EC%9E%90%28%EB%8F%85%EA%B0%90%29A%C2%B7B%EB%B0%94%EC%9D%B4%EB%9F%AC%EC%8A%A4%ED%95%AD%EC%9B%90%EA%B2%80%EC%82%AC+%5B%ED%98%84%EC%9E%A5%EA%B2%80%EC%82%AC%5D."},{"key":"10.1016\/j.vaccine.2026.128533_bb0230","unstructured":"Health Insurance Review & Assessment Service. Weighted average by molecule [Internet]. [cited 2025 Apr 7]. Available from: https:\/\/www.hira.or.kr\/bbsDummy.do?pgmid=HIRAA030017000000&brdScnBltNo=4&brdBltNo=1634&pageIndex=1&pageIndex2=1#none."},{"key":"10.1016\/j.vaccine.2026.128533_bb0235","unstructured":"Health Insurance Review & Assessment Service. [Act] Medical and Dental Fee File ('24.11.1.)_Symptom and behavior assessment scales (including full version) [Internet]. [cited 2025 Apr 7]. Available from: https:\/\/www.hira.or.kr\/bbsDummy.do?pgmid=HIRAA020002000100&brdScnBltNo=4&brdBltNo=11172&pageIndex=3&pageIndex2=3#none."},{"key":"10.1016\/j.vaccine.2026.128533_bb0240","unstructured":"Taiwan CDC. 2024 governmental\/TCDC budget [Internet]. [cited 2025 Apr 8]. Available from: https:\/\/www.cdc.gov.tw\/Home\/Error404?aspxerrorpath=\/Uploads\/files\/6701507d-9f07-4bf9-b627-2e3731d34513."},{"key":"10.1016\/j.vaccine.2026.128533_bb0245","unstructured":"KOSIS. Korea CPI 2024 [Internet]. [cited 2025 May 9]. Available from: https:\/\/kosis.kr\/statHtml\/statHtml.do?sso=ok&returnurl=https%3A%2F%2Fkosis.kr%3A443%2FstatHtml%2FstatHtml.do%3Fconn_path%3DI3%26tblId%3DDT_1J22003%26orgId%3D101%26."},{"key":"10.1016\/j.vaccine.2026.128533_bb0250","unstructured":"National Statistics, Republic of China (Taiwan)-CPI Change Rate [Internet]. [cited 2025 Jan 23]. Available from: https:\/\/eng.stat.gov.tw\/Point.aspx?sid=t.2&n=4201&sms=11713."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:01:00Z","timestamp":1792515660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"alternative-id":["S0264410X26003415"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128533","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of vaccination of older adults with an MF59\u00ae-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in South Korea and Taiwan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128533"}}